Vault-13

Rhenman & Partners Asset Management AB

Stockholm, V7 · CIK 1599882 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.1bn reported value +30.7% vs Q1 2026
99positions
25.1%in top 10
21 new 41 added 34 reduced 8 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITEDHEALTH GROUP INC COM UNH UNH 93,600 $38.9m3.67% 3.67% AddedShares held: Q3 2025 62.5k, Q4 2025 54.9k, Q1 2026 45.5k, Q2 2026 93.6k +48.1k +48,100 105.7%
2 CVS HEALTH CORP COM CVS CVS 279,374 $28.9m2.73% 2.73% ReducedShares held: Q3 2025 277.4k, Q4 2025 335.5k, Q1 2026 336.5k, Q2 2026 279.4k -57.1k -57,126 -17.0%
3 ASTRAZENECA PLC ORD AZN AZN 151,500 $28.5m2.69% 2.69% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 151.5k
4 MERCK & CO INC COM MRK MRK 213,500 $27.4m2.59% 2.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 213.5k
5 ELI LILLY & CO COM LLY LLY 22,315 $26.8m2.53% 2.53% ReducedShares held: Q3 2025 53.4k, Q4 2025 42.2k, Q1 2026 33.7k, Q2 2026 22.3k -11.4k -11,400 -33.8%
6 ABBVIE INC COM ABBV ABBV 96,775 $24.4m2.30% 2.30% AddedShares held: Q3 2025 130.4k, Q4 2025 110.6k, Q1 2026 71.6k, Q2 2026 96.8k +25.2k +25,200 35.2%
7 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 997,083 $23.7m2.24% 2.24% ReducedShares held: Q3 2025 1.5m, Q4 2025 1.0m, Q1 2026 1.1m, Q2 2026 997.1k -56.4k -56,367 -5.3%
8 EDWARDS LIFESCIENCES CORP COM EW EW 260,000 $23.5m2.22% 2.22% AddedShares held: Q3 2025 155.0k, Q4 2025 193.5k, Q1 2026 163.0k, Q2 2026 260.0k +97.0k +97,000 59.5%
9 GILEAD SCIENCES INC COM GILD GILD 178,250 $22.5m2.13% 2.13% AddedShares held: Q3 2025 80.2k, Q4 2025 126.2k, Q1 2026 167.8k, Q2 2026 178.2k +10.5k +10,500 6.3%
10 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 87,440 $21.1m1.99% 1.99% AddedShares held: Q3 2025 95.0k, Q4 2025 74.0k, Q1 2026 75.9k, Q2 2026 87.4k +11.6k +11,550 15.2%
11 BIOGEN INC COM BIIB BIIB 94,850 $20.5m1.93% 1.93% ReducedShares held: Q3 2025 55.0k, Q4 2025 92.3k, Q1 2026 109.1k, Q2 2026 94.8k -14.2k -14,250 -13.1%
12 STRYKER CORPORATION COM SYK SYK 65,000 $20.5m1.93% 1.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 47.8k, Q2 2026 65.0k +17.2k +17,200 36.0%
13 BOSTON SCIENTIFIC CORP COM BSX BSX 450,500 $19.2m1.81% 1.81% ReducedShares held: Q3 2025 438.0k, Q4 2025 431.2k, Q1 2026 625.0k, Q2 2026 450.5k -174.5k -174,500 -27.9%
14 JOHNSON & JOHNSON COM JNJ JNJ 72,500 $18.4m1.74% 1.74% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 72.5k
15 GUARDANT HEALTH INC COM GH GH 115,000 $17.3m1.63% 1.63% ReducedShares held: Q3 2025 50.0k, Q4 2025 80.0k, Q1 2026 145.0k, Q2 2026 115.0k -30.0k -30,000 -20.7%
16 REGENERON PHARMACEUTICALS COM REGN REGN 27,390 $17.1m1.61% 1.61% ReducedShares held: Q3 2025 36.1k, Q4 2025 61.4k, Q1 2026 48.1k, Q2 2026 27.4k -20.7k -20,710 -43.1%
17 GLAUKOS CORP COM GKOS GKOS 119,000 $16.6m1.57% 1.57% AddedShares held: Q3 2025 230.0k, Q4 2025 210.0k, Q1 2026 84.0k, Q2 2026 119.0k +35.0k +35,000 41.7%
18 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 290,500 $16.6m1.57% 1.57% AddedShares held: Q3 2025 186.7k, Q4 2025 215.0k, Q1 2026 207.0k, Q2 2026 290.5k +83.5k +83,500 40.3%
19 NURIX THERAPEUTICS INC COM NRIX NRIX 684,250 $16.6m1.57% 1.57% AddedShares held: Q3 2025 347.5k, Q4 2025 537.5k, Q1 2026 313.5k, Q2 2026 684.2k +370.8k +370,750 118.3%
20 NATERA INC COM NTRA NTRA 61,050 $16.6m1.56% 1.56% AddedShares held: Q3 2025 31.0k, Q4 2025 40.5k, Q1 2026 51.6k, Q2 2026 61.0k +9.4k +9,450 18.3%
21 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 139,205 $16.3m1.54% 1.54% AddedShares held: Q3 2025 56.3k, Q4 2025 106.3k, Q1 2026 92.6k, Q2 2026 139.2k +46.6k +46,600 50.3%
22 INSMED INC COM PAR $.01 INSM INSM 151,960 $16.2m1.53% 1.53% ReducedShares held: Q3 2025 131.9k, Q4 2025 113.6k, Q1 2026 159.8k, Q2 2026 152.0k -7.8k -7,800 -4.9%
23 TENET HEALTHCARE CORP COM NEW THC THC 85,200 $15.9m1.50% 1.50% AddedShares held: Q3 2025 58.4k, Q4 2025 76.5k, Q1 2026 54.0k, Q2 2026 85.2k +31.2k +31,200 57.8%
24 THERMO FISHER SCIENTIFIC INC COM TMO TMO 31,580 $15.8m1.49% 1.49% ReducedShares held: Q3 2025 30.0k, Q4 2025 33.6k, Q1 2026 41.3k, Q2 2026 31.6k -9.8k -9,760 -23.6%
25 CENTENE CORP DEL COM CNC CNC 244,000 $15.7m1.48% 1.48% NewShares held: Q3 2025 170.0k, Q4 2025 46.2k, Q1 2026 0, Q2 2026 244.0k
26 AXSOME THERAPEUTICS INC COM AXSM AXSM 63,050 $15.4m1.46% 1.46% ReducedShares held: Q3 2025 172.8k, Q4 2025 114.8k, Q1 2026 63.8k, Q2 2026 63.0k -750 -750 -1.2%
27 DANAHER CORPORATION COM DHR DHR 80,252 $15.3m1.44% 1.44% AddedShares held: Q3 2025 134.5k, Q4 2025 99.1k, Q1 2026 18.1k, Q2 2026 80.3k +62.2k +62,200 344.6%
28 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 30,685 $15.2m1.44% 1.44% ReducedShares held: Q3 2025 47.0k, Q4 2025 34.3k, Q1 2026 43.5k, Q2 2026 30.7k -12.8k -12,800 -29.4%
29 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 1,538,625 $15.2m1.43% 1.43% AddedShares held: Q3 2025 1.3m, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 1.5m +100.0k +100,000 7.0%
30 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 85,841 $14.5m1.37% 1.37% ReducedShares held: Q3 2025 114.7k, Q4 2025 125.5k, Q1 2026 100.8k, Q2 2026 85.8k -15.0k -15,000 -14.9%
31 PENNANT GROUP INC COM PNTG PNTG 371,471 $13.7m1.30% 1.30% AddedShares held: Q3 2025 0, Q4 2025 357.3k, Q1 2026 275.4k, Q2 2026 371.5k +96.1k +96,072 34.9%
32 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 34,500 $13.7m1.30% 1.30% ReducedShares held: Q3 2025 48.5k, Q4 2025 48.0k, Q1 2026 36.8k, Q2 2026 34.5k -2.3k -2,346 -6.4%
33 ELEVANCE HEALTH INC COM ELV ELV 34,900 $13.5m1.27% 1.27% AddedShares held: Q3 2025 22.5k, Q4 2025 15.0k, Q1 2026 32.3k, Q2 2026 34.9k +2.6k +2,600 8.1%
34 LIVANOVA PLC SHS LIVN LIVN 164,000 $13.5m1.27% 1.27% AddedShares held: Q3 2025 53.0k, Q4 2025 190.0k, Q1 2026 155.0k, Q2 2026 164.0k +9.0k +9,000 5.8%
35 CENCORA INC COM COR COR 46,778 $13.2m1.25% 1.25% ReducedShares held: Q3 2025 62.4k, Q4 2025 63.4k, Q1 2026 52.4k, Q2 2026 46.8k -5.6k -5,597 -10.7%
36 CHARLES RIV LABS INTL INC COM CRL CRL 57,200 $13.0m1.22% 1.22% AddedShares held: Q3 2025 0, Q4 2025 22.0k, Q1 2026 26.0k, Q2 2026 57.2k +31.2k +31,200 120.0%
37 IDEAYA BIOSCIENCES INC COM IDYA IDYA 343,800 $12.8m1.21% 1.21% AddedShares held: Q3 2025 0, Q4 2025 250.0k, Q1 2026 255.5k, Q2 2026 343.8k +88.3k +88,300 34.6%
38 MCKESSON CORP COM MCK MCK 16,550 $12.5m1.18% 1.18% ReducedShares held: Q3 2025 26.6k, Q4 2025 25.6k, Q1 2026 16.9k, Q2 2026 16.6k -300 -300 -1.8%
39 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 560,250 $12.2m1.16% 1.16% AddedShares held: Q3 2025 574.0k, Q4 2025 487.0k, Q1 2026 379.2k, Q2 2026 560.2k +181.0k +181,000 47.7%
40 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 165,896 $11.6m1.09% 1.09% AddedShares held: Q3 2025 60.0k, Q4 2025 198.0k, Q1 2026 50.0k, Q2 2026 165.9k +115.9k +115,896 231.8%
41 MEDTRONIC PLC SHS MDT MDT 145,000 $11.3m1.07% 1.07% AddedShares held: Q3 2025 205.0k, Q4 2025 296.0k, Q1 2026 90.0k, Q2 2026 145.0k +55.0k +55,000 61.1%
42 MINERALYS THERAPEUTICS INC COM MLYS MLYS 416,371 $11.2m1.06% 1.06% AddedShares held: Q3 2025 165.0k, Q4 2025 142.6k, Q1 2026 263.1k, Q2 2026 416.4k +153.3k +153,300 58.3%
43 OSCAR HEALTH INC CL A OSCR OSCR 392,000 $11.2m1.06% 1.06% ReducedShares held: Q3 2025 0, Q4 2025 260.0k, Q1 2026 660.0k, Q2 2026 392.0k -268.0k -268,000 -40.6%
44 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 197,000 $11.0m1.04% 1.04% ReducedShares held: Q3 2025 258.5k, Q4 2025 206.5k, Q1 2026 233.0k, Q2 2026 197.0k -36.0k -36,000 -15.4%
45 DEXCOM INC COM DXCM DXCM 160,000 $10.8m1.02% 1.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 160.0k
46 ALIGN TECHNOLOGY INC COM ALGN ALGN 63,000 $10.6m1.00% 1.00% AddedShares held: Q3 2025 83.0k, Q4 2025 99.0k, Q1 2026 7.5k, Q2 2026 63.0k +55.5k +55,500 740.0%
47 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 119,300 $10.6m1.00% 1.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 119.3k
48 RELAY THERAPEUTICS INC COM RLAY RLAY 566,000 $10.6m1.00% 1.00% AddedShares held: Q3 2025 460.0k, Q4 2025 460.0k, Q1 2026 360.0k, Q2 2026 566.0k +206.0k +206,000 57.2%
49 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 128,000 $10.4m0.98% 0.98% ReducedShares held: Q3 2025 0, Q4 2025 144.5k, Q1 2026 144.5k, Q2 2026 128.0k -16.5k -16,500 -11.4%
50 AGILENT TECHNOLOGIES INC COM A A 75,000 $10.0m0.94% 0.94% AddedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 25.0k, Q2 2026 75.0k +50.0k +50,000 200.0%
51 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 141,250 $9.9m0.93% 0.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 59.0k, Q2 2026 141.2k +82.2k +82,250 139.4%
52 ALKERMES PLC SHS ALKS ALKS 185,250 $9.7m0.92% 0.92% AddedShares held: Q3 2025 94.0k, Q4 2025 133.2k, Q1 2026 133.2k, Q2 2026 185.2k +52.0k +52,000 39.0%
53 ABBOTT LABS COM ABT ABT 96,000 $8.7m0.82% 0.82% ReducedShares held: Q3 2025 98.5k, Q4 2025 0, Q1 2026 112.0k, Q2 2026 96.0k -16.0k -16,000 -14.3%
54 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 86,127 $8.4m0.79% 0.79% AddedShares held: Q3 2025 173.6k, Q4 2025 98.6k, Q1 2026 81.6k, Q2 2026 86.1k +4.5k +4,500 5.5%
55 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 345,000 $7.8m0.74% 0.74% ReducedShares held: Q3 2025 390.0k, Q4 2025 611.0k, Q1 2026 475.0k, Q2 2026 345.0k -130.0k -130,000 -27.4%
56 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 145,100 $7.8m0.74% 0.74% AddedShares held: Q3 2025 180.1k, Q4 2025 147.6k, Q1 2026 128.1k, Q2 2026 145.1k +17.0k +17,000 13.3%
57 ORUKA THERAPEUTICS INC COM ORKA ORKA 80,000 $7.6m0.72% 0.72% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
58 ENCOMPASS HEALTH CORP COM EHC EHC 74,263 $7.5m0.71% 0.71% AddedShares held: Q3 2025 119.4k, Q4 2025 146.3k, Q1 2026 56.3k, Q2 2026 74.3k +18.0k +18,000 32.0%
59 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 384,800 $7.5m0.71% 0.71% AddedShares held: Q3 2025 207.0k, Q4 2025 364.0k, Q1 2026 239.5k, Q2 2026 384.8k +145.3k +145,300 60.7%
60 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,705,327 $7.1m0.67% 0.67% ReducedShares held: Q3 2025 1.1m, Q4 2025 1.6m, Q1 2026 2.1m, Q2 2026 1.7m -350.0k -350,000 -17.0%
61 BRIDGEBIO PHARMA INC COM BBIO BBIO 91,100 $6.8m0.64% 0.64% AddedShares held: Q3 2025 0, Q4 2025 81.6k, Q1 2026 90.6k, Q2 2026 91.1k +500 +500 0.6%
62 KURA ONCOLOGY INC COM KURA KURA 591,500 $6.5m0.61% 0.61% AddedShares held: Q3 2025 490.0k, Q4 2025 872.0k, Q1 2026 271.5k, Q2 2026 591.5k +320.0k +320,000 117.9%
63 INSULET CORP COM PODD PODD 42,000 $6.4m0.60% 0.60% AddedShares held: Q3 2025 58.0k, Q4 2025 61.0k, Q1 2026 14.0k, Q2 2026 42.0k +28.0k +28,000 200.0%
64 ERASCA INC COM ERAS ERAS 349,000 $6.4m0.60% 0.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 349.0k
65 KRYSTAL BIOTECH INC COM KRYS KRYS 16,325 $6.1m0.57% 0.57% ReducedShares held: Q3 2025 11.8k, Q4 2025 25.0k, Q1 2026 16.7k, Q2 2026 16.3k -350 -350 -2.1%
66 STEVANATO GROUP S P A ORD SHS STVN STVN 305,972 $5.5m0.52% 0.52% AddedShares held: Q3 2025 51.0k, Q4 2025 147.0k, Q1 2026 274.7k, Q2 2026 306.0k +31.3k +31,296 11.4%
67 ASTRANA HEALTH INC COM NEW ASTH ASTH 118,888 $5.5m0.52% 0.52% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 118.9k
68 CARDINAL HEALTH INC COM CAH CAH 22,500 $5.3m0.50% 0.50% ReducedShares held: Q3 2025 94.0k, Q4 2025 0, Q1 2026 27.0k, Q2 2026 22.5k -4.5k -4,500 -16.7%
69 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 17,200 $5.2m0.49% 0.49% ReducedShares held: Q3 2025 31.9k, Q4 2025 45.7k, Q1 2026 34.5k, Q2 2026 17.2k -17.3k -17,265 -50.1%
70 MOLINA HEALTHCARE INC COM MOH MOH 21,857 $5.0m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.9k
71 VIKING THERAPEUTICS INC COM VKTX VKTX 128,000 $5.0m0.47% 0.47% ReducedShares held: Q3 2025 216.3k, Q4 2025 83.0k, Q1 2026 160.0k, Q2 2026 128.0k -32.0k -32,000 -20.0%
72 THE CIGNA GROUP COM CI CI 17,400 $4.8m0.45% 0.45% AddedShares held: Q3 2025 46.5k, Q4 2025 38.6k, Q1 2026 8.0k, Q2 2026 17.4k +9.4k +9,400 117.5%
73 IONIS PHARMACEUTICALS INC COM IONS IONS 59,900 $4.7m0.45% 0.45% ReducedShares held: Q3 2025 310.0k, Q4 2025 158.5k, Q1 2026 92.9k, Q2 2026 59.9k -33.0k -33,000 -35.5%
74 AMN HEALTHCARE SVCS INC COM AMN AMN 144,466 $4.7m0.44% 0.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 144.5k
75 DENALI THERAPEUTICS INC COM DNLI DNLI 179,000 $4.6m0.43% 0.43% ReducedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 199.0k, Q2 2026 179.0k -20.0k -20,000 -10.1%
76 MEDPACE HLDGS INC COM MEDP MEDP 8,500 $4.5m0.42% 0.42% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.5k
77 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 8,050 $4.3m0.41% 0.41% ReducedShares held: Q3 2025 18.2k, Q4 2025 19.6k, Q1 2026 24.1k, Q2 2026 8.1k -16.0k -16,000 -66.5%
78 AMGEN INC COM AMGN AMGN 11,900 $4.3m0.41% 0.41% ReducedShares held: Q3 2025 0, Q4 2025 36.0k, Q1 2026 15.2k, Q2 2026 11.9k -3.3k -3,300 -21.7%
79 SIONNA THERAPEUTICS INC COM SION SION 97,100 $4.3m0.40% 0.40% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 87.5k, Q2 2026 97.1k +9.6k +9,600 11.0%
80 ASCENDIS PHARMA A/S ORD SHS ASND ASND 15,000 $4.0m0.38% 0.38% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.0k
81 COOPER COS INC COM COO COO 54,000 $3.9m0.37% 0.37% AddedShares held: Q3 2025 237.0k, Q4 2025 327.5k, Q1 2026 50.0k, Q2 2026 54.0k +4.0k +4,000 8.0%
82 WAYSTAR HLDG CORP COM WAY WAY 178,566 $3.7m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 342.6k, Q2 2026 178.6k -164.0k -164,000 -47.9%
83 MBX BIOSCIENCES INC COM MBX MBX 62,000 $3.4m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 62.0k
84 VERICEL CORP COM VCEL VCEL 70,000 $3.1m0.29% 0.29% UnchangedShares held: Q3 2025 117.0k, Q4 2025 117.0k, Q1 2026 70.0k, Q2 2026 70.0k
85 VEEVA SYS INC CL A COM VEEV VEEV 17,300 $3.1m0.29% 0.29% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 85.3k, Q2 2026 17.3k -68.0k -68,000 -79.7%
86 BICARA THERAPEUTICS INC COM BCAX BCAX 88,150 $2.6m0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 88.2k
87 STERIS PLC SHS USD STE STE 11,500 $2.4m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 6.0k, Q1 2026 11.5k, Q2 2026 11.5k
88 OCULAR THERAPEUTIX INC COM OCUL OCUL 225,000 $2.2m0.21% 0.21% ReducedShares held: Q3 2025 202.0k, Q4 2025 265.0k, Q1 2026 305.0k, Q2 2026 225.0k -80.0k -80,000 -26.2%
89 STOKE THERAPEUTICS INC COM STOK STOK 64,500 $2.1m0.20% 0.20% ReducedShares held: Q3 2025 250.0k, Q4 2025 216.0k, Q1 2026 83.0k, Q2 2026 64.5k -18.5k -18,500 -22.3%
90 XENON PHARMACEUTICALS INC COM XENE XENE 33,250 $2.0m0.19% 0.19% AddedShares held: Q3 2025 81.0k, Q4 2025 139.0k, Q1 2026 28.0k, Q2 2026 33.2k +5.2k +5,250 18.8%
91 DOXIMITY INC CL A DOCS DOCS 76,107 $1.6m0.15% 0.15% ReducedShares held: Q3 2025 136.0k, Q4 2025 372.8k, Q1 2026 183.8k, Q2 2026 76.1k -107.7k -107,701 -58.6%
92 PRIVIA HEALTH GROUP INC COM PRVA PRVA 50,000 $1.3m0.12% 0.12% NewShares held: Q3 2025 194.2k, Q4 2025 125.0k, Q1 2026 0, Q2 2026 50.0k
93 NOVOCURE LTD ORD SHS NVCR NVCR 70,000 $1.1m0.10% 0.10% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 70.0k, Q2 2026 70.0k
94 MINIMED GROUP INC COM MMED MMED 55,000 $822.2k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.0k
95 ALPHATEC HLDGS INC COM NEW ATEC ATEC 85,000 $735.2k0.07% 0.07% AddedShares held: Q3 2025 18.0k, Q4 2025 20.0k, Q1 2026 70.0k, Q2 2026 85.0k +15.0k +15,000 21.4%
96 AGILON HEALTH INC COM NEW AGL AGL 5,000 $535.9k0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.0k
97 10X GENOMICS INC CL A COM TXG TXG 8,500 $325.9k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.5k
98 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 20,000 $301.8k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
99 TG THERAPEUTICS INC COM TGTX TGTX 5,000 $274.7k0.03% 0.03% NewShares held: Q3 2025 93.0k, Q4 2025 73.2k, Q1 2026 0, Q2 2026 5.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ADAPTIVE BIOTECHNOLOGIES COR ADPT ADPT 720,000 $10.0m720.0k shares
IQVIA HLDGS INC IQV IQV 53,000 $9.0m53.0k shares
NUVALENT INC 81,200 $8.3m81.2k shares
APOGEE THERAPEUTICS INC 75,000 $6.3m75.0k shares
ASCENDIS PHARMA A/S 15,000 $3.4m15.0k shares
ESPERION THERAPEUTICS INC NE ESPR ESPR 985,000 $2.7m985.0k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 85,724 $2.6m85.7k shares
COMPASS THERAPEUTICS INC CMPX CMPX 115,113 $608.9k115.1k shares